**Education:** 2011.9 - 2014.07 The First Affiliated Hospital, Sun Yat-sen University, Oncology (Radiation Therapy), Ph.D. 2012.9 - 2012.12 Beth Israel Cancer Center, Albert Einstein College of Medicine, USA, Clinical Observer 2004.9 - 2007.7 Sun Yat-sen University Cancer Center, Oncology (Radiation Therapy), Master's Degree 1998.9 - 2003.7 Zhengzhou University, Clinical Medicine, Bachelor's Degree **Professional Experience:** 2014.07 - Present Department of Radiation Therapy, The First Affiliated Hospital, Sun Yat-sen University 2010.07 - 2011.08 Department of Radiation Oncology, The Fifth Affiliated Hospital, Sun Yat-sen University, Resident Physician 2007.08 - 2010.07 Sun Yat-sen University Cancer Center, Radiation Oncology Specialist Training Physician **Representative Publications:** 1. Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial. *Lancet EClinicalMedicine*, 2022; IF=17.033 2. Pretreatment BMI as an independent prognostic factor in patients with locoregionally advanced NPC treated with chemoradiotherapy: Findings from a randomized trial. *EJC*, 2013; IF=10.002 3. Association between Pretreatment Serum High-density Lipoprotein Cholesterol and Treatment Outcomes in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a Randomised Trial. *JOC*, 2019; IF=4.478